Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Zinc finger MYM-type protein 1 (ZMYM1)** is a member of the zinc finger protein family that coordinates zinc ions to stabilize its conformation and facilitate interactions with DNA, RNA, or other proteins[1][5]. ZMYM1 contains MYM-type zinc finger motifs and is predicted to participate in protein-protein interactions and transcriptional regulation, largely localized to the cell nucleus[2]. Zinc finger proteins as a family are important for genome stability, chromatin remodeling, and transcriptional regulation[1][5]. The detailed biological function and disease relevance of ZMYM1 specifically remain incompletely characterized, but related zinc finger proteins have broad involvement in cellular pathways critical for health and disease[1][5]. There are no known drugs or clinical biomarkers specific to ZMYM1 as of 2025[2][4].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger MYM-type protein 1 (ZMYM1).